US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US7381413B1
(en)
*
|
1998-04-17 |
2008-06-03 |
University Of Vermont And State Agricultural College |
Methods and products related to metabolic interactions in disease
|
EP1205493A1
(en)
*
|
2000-11-14 |
2002-05-15 |
ATOFINA Research |
Polymerisation catalyst systems and their preparation
|
US7666459B2
(en)
|
2001-09-12 |
2010-02-23 |
The Procter & Gamble Company |
Pet food compositions
|
US7547673B2
(en)
*
|
2001-09-13 |
2009-06-16 |
The Johns Hopkins University |
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
|
JP2006515885A
(ja)
*
|
2003-01-17 |
2006-06-08 |
スレッシュオールド ファーマシューティカルズ, インコーポレイテッド |
癌の処置のための併用療法
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
WO2005070126A2
(en)
*
|
2004-01-08 |
2005-08-04 |
The Regents Of The University Of Colorado |
Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors
|
DK1711188T3
(da)
|
2004-02-06 |
2012-09-10 |
Threshold Pharmaceuticals Inc |
Anticancerterapier
|
US20090252834A1
(en)
*
|
2004-05-10 |
2009-10-08 |
Michael Griffin Hayek |
Compositions comprising glucose anti-metabolites
|
CN1972697A
(zh)
|
2004-06-17 |
2007-05-30 |
威斯康星校友研究基地 |
治疗发作和发作性疾病的化合物和方法
|
US20070292478A1
(en)
*
|
2004-08-30 |
2007-12-20 |
Popowski Youri |
Medical Implant Provided with Inhibitors of Atp Synthesis
|
US20060078580A1
(en)
*
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
US7740875B2
(en)
*
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
MX2007004893A
(es)
*
|
2004-11-02 |
2007-06-14 |
Conforma Therapeutics Corp |
Metodos y composiciones para el tratamiento de leucemia linfocitica cronica.
|
MX2007009960A
(es)
*
|
2005-02-18 |
2008-03-11 |
Abraxis Bioscience Inc |
Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US7208611B2
(en)
|
2005-02-23 |
2007-04-24 |
Xenoport, Inc. |
Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use
|
WO2006108681A2
(en)
|
2005-04-15 |
2006-10-19 |
Biomac Privatinstitut Für Medizinische Und Zahnmedizinische Forschung, Entwicklung Und Diagnostik Gmbh |
Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
|
CA2607949C
(en)
|
2005-05-31 |
2012-09-25 |
Thomas William-Maxwell Boileau |
Feline probiotic bifidobacteria
|
AR052472A1
(es)
|
2005-05-31 |
2007-03-21 |
Iams Company |
Lactobacilos probioticos para felinos
|
US20060287253A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kriegler Steven M |
Compounds and methods for treating seizure disorders
|
EP1902732A4
(en)
*
|
2005-06-24 |
2009-07-22 |
Takeda Pharmaceutical |
PROPHYLACTIC / THERAPEUTIC AGENT AGAINST HER2-EXPRESSIVE CANCER
|
US20070032383A1
(en)
*
|
2005-07-27 |
2007-02-08 |
Newell M K |
Systems, methods, and compositions for modifying the metabolism of plants and of euucaryotic microbes
|
US20070134349A1
(en)
*
|
2005-09-19 |
2007-06-14 |
Duke University |
Methods of treating hematological malignancies
|
WO2007064448A2
(en)
*
|
2005-11-28 |
2007-06-07 |
Ramot At Tel Aviv University, Ltd. |
Cancer treatment using fts and 2-deoxyglucose
|
WO2007067516A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Duke University |
Multiple myeloma
|
US8324175B2
(en)
|
2006-02-16 |
2012-12-04 |
Young Hee Ko |
Compositions and methods for the treatment of cancer
|
US7754693B2
(en)
*
|
2006-02-16 |
2010-07-13 |
Young Hee Ko |
Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
|
KR20080096807A
(ko)
*
|
2006-02-24 |
2008-11-03 |
보오드 오브 리젠츠, 더 유니버시티 오브 텍사스 시스템 |
암 치료용 6탄당 화합물
|
EP1991056A4
(en)
*
|
2006-02-24 |
2009-09-02 |
Univ Miami |
MANNOSEDERIVATES FOR THE KILLING OF TUMOR CELLS
|
US9149489B2
(en)
*
|
2006-04-27 |
2015-10-06 |
Board Of Regents, University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
WO2009108926A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
US20090156660A1
(en)
*
|
2006-05-03 |
2009-06-18 |
Michal Svoboda |
Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
|
WO2008062780A1
(en)
|
2006-11-20 |
2008-05-29 |
National University Corporation Kagawa University |
Deoxyketohexose isomerase and method for producing deoxyketohexose and derivative thereof using the same
|
WO2008076964A1
(en)
*
|
2006-12-18 |
2008-06-26 |
The Johns Hopkins University |
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of atp production
|
AU2008211600B8
(en)
|
2007-02-01 |
2014-02-13 |
Mars, Incorporated |
Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
|
US8865646B2
(en)
*
|
2007-03-28 |
2014-10-21 |
University Of South California |
Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
|
US8211700B2
(en)
*
|
2007-03-28 |
2012-07-03 |
University Of Southern California |
Induction of differential stress resistance and uses thereof
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
US8765690B2
(en)
*
|
2007-04-05 |
2014-07-01 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with glufosfamide in patients not receiving insulin therapy
|
WO2009102986A1
(en)
*
|
2008-02-15 |
2009-08-20 |
Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center) |
Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox1 inhibitor
|
CA2716321A1
(en)
*
|
2008-02-21 |
2009-08-27 |
The Regents Of The University Of Colorado |
Methods for treating cancer using combination therapy
|
AU2009242453B2
(en)
|
2008-05-02 |
2014-12-04 |
Seagen Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
WO2009143515A2
(en)
*
|
2008-05-23 |
2009-11-26 |
University Of Miami |
Treatment using continuous low dose application of sugar analogs
|
WO2009143611A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Oncolytics Biotech Inc. |
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
PL2310020T3
(pl)
*
|
2008-07-11 |
2017-10-31 |
Univ Texas |
Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej
|
US9073985B2
(en)
|
2008-07-14 |
2015-07-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods and products for treating proliferative diseases
|
WO2010019396A1
(en)
*
|
2008-08-13 |
2010-02-18 |
Threshold Pharmaceuticals, Inc. |
Administration of glufosfamide for the treatment of cancer
|
US9492417B2
(en)
*
|
2008-08-21 |
2016-11-15 |
The Johns Hopkins University |
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
|
UA104147C2
(uk)
*
|
2008-09-10 |
2014-01-10 |
Новартис Аг |
Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
|
KR20110110355A
(ko)
*
|
2009-01-29 |
2011-10-06 |
영희 고 |
암 치료용 조성물 및 방법
|
EP2406389B1
(en)
|
2009-03-13 |
2019-05-08 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
DK2448582T3
(en)
|
2009-06-29 |
2017-07-17 |
Agios Pharmaceuticals Inc |
QUINOLIN-8 SULPHONAMIDE DERIVATIVES WITH ANTICANCER ACTIVITY
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
US8450090B2
(en)
|
2009-10-06 |
2013-05-28 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for promoting fatty acid production in plants
|
EP3561077B1
(en)
|
2009-10-21 |
2022-12-21 |
Les Laboratoires Servier |
Methods for cell-proliferation-related disorders
|
WO2011050211A2
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
NZ599996A
(en)
|
2009-10-22 |
2014-06-27 |
Propanc Pty Ltd |
A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
|
CN102115483B
(zh)
*
|
2009-12-30 |
2014-12-17 |
苏州天人合生物技术有限公司 |
卤代双去氧糖衍生物及其制备方法与应用
|
GB2478556A
(en)
*
|
2010-03-09 |
2011-09-14 |
Myrovlytis Technology Ventures Ltd |
A composition for use in the treatment of Birt-Hogg-Dubô sydrome
|
CN107158389A
(zh)
|
2010-03-29 |
2017-09-15 |
阿布拉科斯生物科学有限公司 |
增强药物递送和治疗剂有效性的方法
|
SG10201906075VA
(en)
|
2010-03-29 |
2019-08-27 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
MY162903A
(en)
|
2010-06-04 |
2017-07-31 |
Abraxis Bioscience Llc |
Methods of treatment of pancreatic cancer
|
WO2012019165A2
(en)
|
2010-08-05 |
2012-02-09 |
Seattle Genetics, Inc. |
Methods of inhibition of protein fucosylation in vivo using fucose analogs
|
KR20140032346A
(ko)
*
|
2010-10-13 |
2014-03-14 |
무스타파 빌진 알리 잠고즈 |
암의 치료/전이의 억제
|
WO2012049439A1
(en)
*
|
2010-10-13 |
2012-04-19 |
Imperial Innovations Limited |
Treatment of cancer/inhibition of metastasis
|
EP2663314A2
(en)
*
|
2011-01-11 |
2013-11-20 |
The University of Texas M.D. Anderson Cancer |
Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
|
WO2012123774A1
(en)
*
|
2011-03-11 |
2012-09-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Glycolytic inhibitor with cytotoxic agent for use in the treatment of a cancer
|
US20120238511A1
(en)
*
|
2011-03-14 |
2012-09-20 |
University Of Southern California |
2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases
|
SI3406251T1
(sl)
|
2011-05-03 |
2024-05-31 |
Agios Pharmaceuticals, Inc. |
Aktivatorji piruvat kinaze za uporabo v terapiji
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
EP2739971A1
(en)
*
|
2011-08-02 |
2014-06-11 |
Roche Diagnostics GmbH |
In vitro tumor metastasis model
|
KR101900478B1
(ko)
*
|
2011-08-04 |
2018-09-20 |
한올바이오파마주식회사 |
암의 재발 또는 전이의 억제용 약제학적 조성물
|
WO2013102431A1
(en)
|
2012-01-06 |
2013-07-11 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
US20160015725A1
(en)
*
|
2012-02-14 |
2016-01-21 |
The Wistar Institute Of Anatomy And Biology |
Methods of controlling tumor bioenergetics networks
|
AU2013202693B2
(en)
*
|
2012-04-16 |
2015-01-22 |
Baxalta GmbH |
Combination Therapy of Anti-MIF Antibodies and Chemotherapeutics
|
WO2014031875A1
(en)
|
2012-08-23 |
2014-02-27 |
Seattle Genetics, Inc. |
Treatment of sickle cell disease and inflammatory conditions
|
AU2013331626B2
(en)
|
2012-10-15 |
2018-08-02 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
WO2014072967A1
(en)
*
|
2012-11-12 |
2014-05-15 |
Urifer Ltd |
Drug combination comprising a glycolysis inhibitor and a tyrosine kinase inhibitor
|
KR101419816B1
(ko)
*
|
2013-01-30 |
2014-07-17 |
(주)제욱 |
상승적 치료 효과를 갖는 비소세포폐암의 예방 또는 치료용 조성물
|
ES2897699T3
(es)
|
2013-04-05 |
2022-03-02 |
Univ Texas |
Esteres de 2-desoxi-monosacáridos con actividad antiproliferativa
|
JP6529492B2
(ja)
|
2013-07-11 |
2019-06-12 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
癌の処置のためのidh2突然変異体阻害剤としての2,4−または4,6−ジアミノピリミジン化合物
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015108933A1
(en)
|
2014-01-14 |
2015-07-23 |
The Johns Hopkins University |
Cyclodextrin compositions encapsulating a selective atp inhibitor and uses thereof
|
MA39726A
(fr)
|
2014-03-14 |
2017-01-18 |
Agios Pharmaceuticals Inc |
Compositions pharmaceutiques de composés thérapeutiquement actifs
|
WO2016065353A1
(en)
*
|
2014-10-24 |
2016-04-28 |
University Of Miami |
Combination therapy with fenofibrate and 2-deoxyglucose or 2-deoxymannose
|
ES2959690T3
(es)
|
2015-06-11 |
2024-02-27 |
Agios Pharmaceuticals Inc |
Procedimientos de uso de activadores de piruvato cinasa
|
MX2018004587A
(es)
|
2015-10-15 |
2018-08-14 |
Agios Pharmaceuticals Inc |
Terapia de combinacion para tratar tumores malignos.
|
WO2017066571A1
(en)
|
2015-10-15 |
2017-04-20 |
Agios Pharmaceuticals, Inc. |
Combination therapy for treating malignancies
|
US10751306B2
(en)
|
2015-11-06 |
2020-08-25 |
The Johns Hopkins University |
Methods of treating liver fibrosis by administering 3-bromopyruvate
|
CN108697771A
(zh)
|
2016-01-29 |
2018-10-23 |
普罗潘克股份有限公司 |
癌症治疗
|
WO2017173360A2
(en)
*
|
2016-03-31 |
2017-10-05 |
Stcube, Inc. |
Combination treatments directed toward programmed death ligand-1 (pd-l1) positive cancers
|
CN110831603A
(zh)
|
2017-06-28 |
2020-02-21 |
株式会社先端医疗开发 |
药物组合物以及肿瘤免疫活性促进剂
|
CN111050764A
(zh)
|
2017-07-21 |
2020-04-21 |
巴克老年研究所 |
β-羟基丁酸酯和丁二醇的S对映异构体及其使用方法
|
US11013733B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
|
US11311527B2
(en)
|
2018-05-16 |
2022-04-26 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
|
WO2019222553A1
(en)
|
2018-05-16 |
2019-11-21 |
Forma Therapeutics, Inc. |
Inhibiting mutant idh-1
|
WO2019222551A1
(en)
|
2018-05-16 |
2019-11-21 |
Forma Therapeutics, Inc. |
Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
|
US11013734B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
RU2707554C1
(ru)
*
|
2019-02-27 |
2019-11-28 |
Федеральное государственное бюджетное учреждение "Петербургский институт ядерной физики им. Б.П. Константинова Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт-ПИЯФ") |
Композиция, ингибирующая рост и выживаемость опухолевых клеток
|
US20230130134A1
(en)
|
2020-03-16 |
2023-04-27 |
Board Of Regents, The University Of Texas System |
Method of treating viral infections with hexose type monosaccharides and analogs thereof
|
US20230092706A1
(en)
*
|
2020-04-16 |
2023-03-23 |
Buck Institute For Research On Aging |
Treatment of viral pathologies with exogenous ketones
|
CN116940371A
(zh)
*
|
2020-12-14 |
2023-10-24 |
Trim生物科技有限公司 |
用于癌症免疫疗法的包含细菌的组合物
|
WO2023062516A1
(en)
*
|
2021-10-11 |
2023-04-20 |
Exploration Invest Pte Ltd |
2-deoxy-d-glucose for use in disease therapy
|
CN114617876B
(zh)
*
|
2022-01-28 |
2023-04-07 |
四川大学华西医院 |
一种抗肿瘤联合用药物
|
KR20240038394A
(ko)
|
2022-09-16 |
2024-03-25 |
이화여자대학교 산학협력단 |
해당과정 억제제 및 미토콘드리아 기능 억제제를 포함하는 암의 예방 또는 치료용 약학적 조성물
|